Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis by Nirajan Niroula, Priya Ghodasara, Nelson Marreros, Bailey Fuller, Haley Sanderson, Slim Zriba, Stew Walker, Todd K. Shury, Jeffrey M. Chen

Subjects: Get full text

Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone Mice by Mariia V. Sergeeva, Kirill Vasilev, Ekaterina Romanovskaya-Romanko, Nikita Yolshin, Anastasia Pulkina, Daria Shamakova, Anna-Polina Shurygina, Arman Muzhikyan, Dmitry Lioznov, Marina Stukova

Subjects: Get full text

Studies on humoral immunity in dogs after use of rabies inactivated vaccines formulated with Montanide ISA 70 VG and GEL 01 adjuvants by A. N. Balashov, M. I. Doronin, A. V. Borisov, D. A. Lozovoy, D. V. Mikhalishin, V. A. Starikov

Subjects: Get full text

Genetically Engineered Bacterial Ghosts as Vaccine Candidates Against <i>Klebsiella pneumoniae</i> Infection by Svetlana V. Dentovskaya, Anastasia S. Vagaiskaya, Alexandra S. Trunyakova, Alena S. Kartseva, Tatiana A. Ivashchenko, Vladimir N. Gerasimov, Mikhail E. Platonov, Victoria V. Firstova, Andrey P. Anisimov

Subjects: Get full text

Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated COVID-19 vaccine by Zhifei Chen, Fangqin Xie, Hairong Zhang, Dong Li, Suhan Zhang, Mengping Zhang, Junrong Li, Jianfeng Xie, Lina Zhang, Xiuhui Yang, Dongjuan Zhang

Subjects: Get full text

Optimization of RHDV type 1 and 2 inactivation modes by E. D. Kunikova, N. V. Moroz, M. A. Dolgova, L. V. Malakhova, I. A. Komarov

Subjects: Get full text

Altered expression of miRNA profile in peripheral blood mononuclear cells following the third dose of inactivated COVID-19 vaccine by Guanguan Qiu, Ruoyang Zhang, Huifeng Qian, Ruoqiong Huang, Jie Xia, Ruoxi Zang, Zhenkai Le, Qiang Shu, Jianguo Xu, Guoping Zheng, Jiangmei Wang

Subjects: Get full text

Use of “ARRIAH-AviFluVac” vaccine in turkeys, geese and ducks by N. V. Moroz, S. V. Frolov, V. N. Irza, L. O. Scherbakova, V. Yu. Kulakov

Subjects: Get full text

Study of immunobiological properties of avian adenovirus serotype 2-based vaccine against adenovirus infection by A. A. Perepecha, S. V. Frolov, D. L. Dolgov, M. A. Volkova, D. A. Gleyzer

Subjects: Get full text

Immunobiological properties of inactivated anti-highly pathogenic avian influenza vaccines based on antigens of А/Н5N1 avian influenza virus strains of different virulence by S. V. Frolov, I. A. Chvala, N. V. Moroz, V. Yu. Kulakov, V. Yu. Sosipatorova, D. B. Andreychuk

Subjects: “…inactivated vaccine…”
Get full text